×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Enabling Patient-Centric Clinical Studies: TransCelerate’s Patient Engagement Tools
Session Chair(s)
Mary Elmer, BSN, MSN, RN
Executive Director, Patient Engagement for Oncology
Merck & Co., Inc., United States
TransCelerate BioPharma is a collaboration of 19 of the world’s leading pharmaceutical organizations that has undertaken a Patient Experience initiative to enable greater patient engagement and partnership between patient and sponsors.
Learning Objective : Describe TransCelerate’s Patient Experience Initiative and the toolkits; Recognize the value of patient engagement in the development of clinical study protocols; Identify the clinical study participant experience as a valuable outcome measure; Appreciate the opportunity for embedding these practices into the development process.
Speaker(s)
Facilitator
Lani Hashimoto
Novartis Pharmaceuticals Corporation, United States
Associate Director, Patient Engagement
Facilitator
Anne Marie Inglis, PhD
Mallinckrodt Pharmaceuticals, United States
Senior Director, Clinical Operations
Facilitator
Christina Cantrell, MSc
Genentech, A Member of the Roche Group, United States
Senior Patient Insights Leader
Have an account?